These projects were made possible from Cure Alzheimer's Fund support.
| Project Description | Researchers | Funding |
|---|---|---|
| Identification and Validation of Plasma-Based Lipid Biomarkers for Early Alzheimer’s Disease in the Unique, Primarily Hispanic, South Texas Population |
2023, 2024 $402,500 |
These published papers resulted from Cure Alzheimer’s Fund support.
Garbarino, V. R., Palavicini, J. P., Melendez, J., Barthelemy, N. R., He, Y., Kautz, T. F., Lopez-Cruzan, M., Mathews, J. J., Xu, P., Zhang, B., Saliba, A., Ragi, N., Sharma, K., Mason, D., Johnson, S., Hendrix, S., Craft, S., Petersen, R. C., … Bateman, R. J., Gonzales, M. M., & Orr, M. E. Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease, Neurotherapeutics, April 23, 2025, Read More
Richardson, T. E., Orr, M. E., Orr, T. C., Rohde, S. K., Ehrenberg, A. J., ... Goate, A. M., ... Kautz, T. F., … Walker, J. M. Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer’s disease, and primary age-related tauopathy hippocampi, Alzheimer's & Dementia, December 31, 2024, Read More